AMARANTUS BIOSCIEN COM USD0.001 (AMBS)

0.03
OTC Markets
Prev Close 0.03
Day Low/High 0.03 / 0.03
52 Wk Low/High 0.01 / 0.09
Exchange OTC Markets
Shares Outstanding 78.79B
Market Cap 2.60M
Div & Yield N.A. (N.A)

Latest News

Amarantus Announces CGMP Manufacturing Readiness For Its Engineered Skin Substitute (ESS) Program At Lonza Walkersville

Amarantus Announces CGMP Manufacturing Readiness For Its Engineered Skin Substitute (ESS) Program At Lonza Walkersville

Amarantus-sponsored training for Phase 2 severe burn trial completed with U.S. Army clinical site in late April

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTC Markets Group, President and CEO R. Cromwell Coulson, will speak on panel "Understanding Reg A+ and the 'Mini IPO'"

Amarantus Announces Capital Infusion

Amarantus Announces Capital Infusion

Avant Diagnostics And Amarantus Diagnostics To Combine Operations With Theranostics Health

Avant Diagnostics And Amarantus Diagnostics To Combine Operations With Theranostics Health

Companies to hold a Conference Call to discuss the business combination today, March 7, 2015 at 4:30pm ET

Amarantus Announces Issuance Of Chinese Patent Covering Use Of MANF For The Treatment Of Parkinson's Disease

Amarantus Announces Issuance Of Chinese Patent Covering Use Of MANF For The Treatment Of Parkinson's Disease

Patent issuance will provide intellectual property protection in China for protein therapy, gene therapy and cell therapy applications of MANF

Amarantus Announces $1M Investment

Amarantus Announces $1M Investment